Oral stem cell factor compound and application

By combining stem cell active factors with albumin peptides and walnut peptides, and adding vitamins and pectin, an oral stem cell factor complex was prepared, which solved the problem of inaccurate effect of stem cell factor complex in the prior art in the treatment of diabetes. It significantly improves the control ability and efficacy of blood sugar and insulin.

CN118987178APending Publication Date: 2024-11-22BEIKEXIN (BEIJING) STEM CELL MEDICAL RES INST CO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411139388.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-19
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The existing stem cell factor complex has inaccurate effect in the treatment of diabetes, complex components and the efficacy needs to be improved.

Method used

A mixture of stem cell activity factor was extracted from bone marrow tissue, and combined with albumin peptide and walnut peptide, vitamins and pectin were added as auxiliary materials to prepare oral preparations to control blood sugar and insulin content.

Benefits of technology

It improves the sugar control effect of the stem cell active factor mixture alone, supplements the vitamin deficiency problem in diabetic patients, improves the active concentration and palatability of oral preparations, and significantly improves the control effect on fasting blood sugar and insulin content.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to the technical field of biological medicine, in particular to an oral stem cell factor compound and application thereof. A stem cell active factor mixture extracted from bone marrow tissue is combined with albumin peptide and walnut peptide to prepare the oral preparation for controlling blood sugar and insulin content. In the preparation, the combination of the albumin peptide and the walnut peptide can improve the sugar control effect of a single stem cell active factor mixture, the addition of the vitamins can improve the current situation of vitamin deficiency in the body of a diabetic patient and effectively make up for recurrent diseases caused by vitamin loss, and the pectin is used as an oral preparation auxiliary material.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedical technology, and in particular to an oral stem cell factor complex and application thereof. Background Art

[0002] Stem cells are cells with multidirectional differentiation potential. Stem cells can differentiate in a specific environment to repair tissue and cell damage. Stem cells can repair tissues by differentiating into specific cells, and paracrine effects play a greater role in tissue repair. In other words, when stem cells are used to treat tissue damage, the cytokines secreted by stem cells play an extremely important role. The system includes more than 20 types of cells, including stem cell factor (SCF), endothelial cell growth factor (VEGF), epidermal cell growth factor (EGF), tumor necrosis factor (TNF), hepatocyte growth factor (HGF), nerve growth factor (NGF), fibroblast growth factor (FGF), insulin-like growth factor (IGF), granulocyte colony stimulating factor (G-CSF), interleukin (IL), etc.

[0003] In recent years, studies have found that stem cells can induce the proliferation and differentiation of their own insulin-secreting stem cells, or stimulate the body's own β-cell function with insulin secretion function, thereby increasing the secretion of insulin, improving the body's own insulin secretion level, and reducing insulin resistance, so that diabetic patients can be separated from drug treatment as much as possible. In addition, stem cells can secrete a large amount of growth factors, improve the local microenvironment of the kidney, promote angiogenesis, and improve the pathological changes caused by diabetic nephropathy. However, the current therapeutic effect of stem cells on diabetes is not certain, and it is still in laboratory tests and clinical trials. Although CN202111480406.0 discloses an oral stem cell factor complex, the components are complex and the therapeutic effect needs to be further improved. Summary of the invention

[0004] In view of the technical problems existing in the prior art, the present invention provides an oral stem cell factor complex and its application. The present invention uses a stem cell active factor mixture extracted from bone marrow tissue and combines albumin peptide and walnut peptide to prepare an oral preparation for controlling blood sugar and insulin content. In the preparation, the combination of albumin peptide and walnut peptide can improve the sugar control effect of the stem cell active factor mixture alone, and the addition of vitamins can improve the current vitamin deficiency in diabetic patients and effectively compensate for the recurrence of symptoms caused by vitamin loss. The role of pectin is as an excipient for oral preparations.

[0005] Specifically, the present invention first provides an oral stem cell factor complex, which includes 10-20% by mass of a stem cell factor mixture, 5-12% albumin peptide, 5-12% yam peptide, 0.5-1.5% vitamin A, 0.2-1.2% vitamin C, 0.001-0.0012% niacin, 0.0002-0.0012% vitamin B6, 0.0001-0.0010% vitamin D, 0.01-0.08% pectin and the remainder of water, and then sterilized and filled to obtain an oral stem cell factor complex.

[0006] Preferably, the stem cell factor complex comprises 10% by mass of a stem cell factor mixture, 5% albumin peptide, 5% yam peptide, 0.5% vitamin A, 0.2% vitamin C, 0.001% niacin, 0.0002% vitamin B6, 0.0001% vitamin D, 0.01% pectin and the remainder of water, and then sterilized and filled to obtain an oral stem cell factor complex.

[0007] Preferably, the stem cell factor complex comprises 15% by mass of a stem cell factor mixture, 8% albumin peptide, 8% yam peptide, 0.8% vitamin A, 0.6% vitamin C, 0.008% niacin, 0.0008% vitamin B6, 0.0008% vitamin D, 0.04% pectin and the remainder of water, and then sterilized and filled to obtain an oral stem cell factor complex.

[0008] Preferably, the stem cell factor complex comprises 20% by mass of a stem cell factor mixture, 12% albumin peptide, 12% yam peptide, 1.5% vitamin A, 1.2% vitamin C, 0.0012% niacin, 0.0012% vitamin B6, 0.0010% vitamin D, 0.08% pectin and the remainder of water, and then is evenly mixed, sterilized and filled to obtain an oral stem cell factor complex.

[0009] Furthermore, the method for preparing the stem cell factor mixture comprises the following steps:

[0010] 1) Obtain single cell suspension from bone marrow tissue digestion and sort CD29 using flow cytometry + CD31 + CD44 + CD14 - CD45 - of bone marrow mesenchymal stem cells;

[0011] 2) Continuously subculture the bone marrow mesenchymal stem cells obtained in step 1) in DMEM basal culture medium;

[0012] 3) collecting the supernatant of bone marrow mesenchymal stem cells from step 2) after three consecutive passages, filtering and sterilizing with a 0.22 μm filter membrane, and purifying and concentrating with an ultrafiltration membrane with a molecular weight cutoff of 20-50 KD to obtain a stem cell active factor concentrate;

[0013] 4) freeze-drying the stem cell active factor concentrate in step 3) to prepare the stem cell factor mixture.

[0014] Furthermore, the amino acid sequence of the albumin peptide is as shown in SEQ ID NO.1; and the preparation method of the albumin peptide comprises:

[0015] 6) washing the eggs, separating the yolk and the egg white, and freeze-drying the egg white to obtain freeze-dried egg white powder;

[0016] 7) mixing the freeze-dried egg white powder with deionized water and adjusting the pH of the mixture to 2.0 to obtain an enzymatic base solution;

[0017] 8) adding 10000U / g pepsin to the enzymatic hydrolysis base solution and performing enzymatic hydrolysis at a temperature of 37°C for 6 hours; after the enzymatic hydrolysis is completed, inactivating the enzyme at 90°C for 10 minutes;

[0018] 9) Centrifuge at 5000 rpm for 10 min and take the supernatant; filter the supernatant using an ultrafiltration membrane with a molecular weight cutoff of 4000-5000 Da polypeptide molecules;

[0019] 10) The albumin peptide is obtained by HPLC separation, purification and freeze-drying.

[0020] Furthermore, the amino acid sequence of the yam peptide is shown in SEQ ID NO.2; and the preparation method of the yam peptide comprises:

[0021] 1) Wash the yam, cut it into pieces, air-dry it at room temperature, and grind the air-dried yam pieces into powder for later use;

[0022] 2) mixing the yam powder obtained in step 1) with water in a weight ratio of 1:5, and adjusting the pH value to 7.5;

[0023] 3) adding papain in step 2) at a final concentration of 50%, and performing enzymatic treatment at a temperature of 37° C. for 6 h;

[0024] 4) Centrifuge at 5000 rpm for 10 min and take the supernatant; filter the supernatant using an ultrafiltration membrane with a molecular weight cutoff of 4000-5000 Da polypeptide molecules;

[0025] 5) The yam peptide is obtained by HPLC separation, purification and freeze-drying.

[0026] On the other hand, the present invention also provides an albumin peptide and a yam peptide, the amino acid sequences of the albumin peptide and the yam peptide are shown in SEQ ID NO.1-2.

[0027] On the other hand, the present invention also provides the use of the albumin peptide and yam peptide in preparing a preparation for improving blood sugar control by stem cell factor complex.

[0028] Preferably, the combination of the albumin peptide and the yam peptide can be used to improve the control of the stem cell factor complex on fasting blood glucose and insulin content.

[0029] On the other hand, the present invention also provides a use of an oral stem cell factor complex in preparing a blood sugar control preparation.

[0030] Preferably, the oral stem cell factor complex can be used for the treatment of diabetic patients.

[0031] The advantages of the present invention are as follows: the present invention utilizes a stem cell active factor mixture extracted from bone marrow tissue and combines albumin peptide and walnut peptide to prepare an oral preparation for controlling blood sugar and insulin content; the oral stem cell factor complex has good palatability and a high concentration of active substances. In the preparation, the combination of albumin peptide and walnut peptide can improve the sugar control effect of a single stem cell active factor mixture, and the addition of vitamins can improve the current vitamin deficiency status in diabetic patients, effectively compensating for recurrent symptoms caused by vitamin loss, and pectin acts as an adjuvant for oral preparations. DETAILED DESCRIPTION

[0032] The present invention is further described in detail below in conjunction with specific embodiments so that those skilled in the art can understand the present invention more clearly.

[0033] The following embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. Based on the specific embodiments of the present invention, all other embodiments obtained by ordinary technicians in the field without creative work belong to the protection scope of the present invention.

[0034] In the examples of the present invention, unless otherwise specified, all raw material components are commercially available products well known to those skilled in the art; in the examples of the present invention, unless otherwise specified, the technical means used are conventional means well known to those skilled in the art.

[0035] Example 1

[0036] The invention discloses an oral stem cell factor complex. The stem cell factor complex comprises 10% by mass of a stem cell factor mixture, 5% of albumin peptide, 5% of yam peptide, 0.5% of vitamin A, 0.2% of vitamin C, 0.001% of niacin, 0.0002% of vitamin B6, 0.0001% of vitamin D, 0.01% of pectin and the remainder of water, and the mixture is evenly mixed, sterilized and filled to obtain the oral stem cell factor complex.

[0037] The method for preparing the stem cell factor mixture comprises the following steps:

[0038] 1) Obtain single cell suspension from bone marrow tissue digestion and sort CD29 using flow cytometry + CD31 + CD44 + CD14 - CD45 - of bone marrow mesenchymal stem cells;

[0039] 2) Continuously subculture the bone marrow mesenchymal stem cells obtained in step 1) in DMEM basal culture medium;

[0040] 3) collecting the supernatant of bone marrow mesenchymal stem cells from step 2) after three consecutive passages, filtering and sterilizing with a 0.22 μm filter membrane, and purifying and concentrating with an ultrafiltration membrane with a molecular weight cutoff of 20-50 KD to obtain a stem cell active factor concentrate;

[0041] 4) freeze-drying the stem cell active factor concentrate in step 3) to prepare the stem cell factor mixture.

[0042] The amino acid sequence of the albumin peptide is shown in SEQ ID NO.1; the preparation method of the albumin peptide comprises:

[0043] 1) washing the eggs, separating the yolk and the egg white, and freeze-drying the egg white to obtain freeze-dried egg white powder;

[0044] 2) mixing the freeze-dried egg white powder with deionized water and adjusting the pH of the mixture to 2.0 to obtain an enzymatic base solution;

[0045] 3) adding 10000U / g pepsin to the enzymatic hydrolysis base solution and performing enzymatic hydrolysis at a temperature of 37°C for 6 hours; after the enzymatic hydrolysis is completed, inactivating the enzyme at 90°C for 10 minutes;

[0046] 4) Centrifuge at 5000 rpm for 10 min and take the supernatant; filter the supernatant using an ultrafiltration membrane with a molecular weight cutoff of 4000-5000 Da polypeptide molecules;

[0047] 5) The albumin peptide is obtained by HPLC separation, purification and freeze-drying.

[0048] The amino acid sequence of the yam peptide is shown in SEQ ID NO.2; the preparation method of the yam peptide comprises:

[0049] 1) Wash the yam, cut it into pieces, air-dry it at room temperature, and grind the air-dried yam pieces into powder for later use;

[0050] 2) mixing the yam powder obtained in step 1) with water in a weight ratio of 1:5, and adjusting the pH value to 7.5;

[0051] 3) adding papain in step 2) at a final concentration of 50%, and performing enzymatic treatment at a temperature of 37° C. for 6 h;

[0052] 4) Centrifuge at 5000 rpm for 10 min and take the supernatant; filter the supernatant using an ultrafiltration membrane with a molecular weight cutoff of 4000-5000 Da polypeptide molecules;

[0053] 5) The yam peptide is obtained by HPLC separation, purification and freeze-drying.

[0054] Example 2

[0055] An oral stem cell factor complex, comprising 15% by mass of a stem cell factor mixture, 8% albumin peptide, 8% yam peptide, 0.8% vitamin A, 0.6% vitamin C, 0.008% niacin, 0.0008% vitamin B6, 0.0008% vitamin D, 0.04% pectin and the remainder of water, and then sterilizing and filling to obtain an oral stem cell factor complex. The preparation methods of the stem cell factor mixture, albumin peptide and yam peptide are the same as those in Example 1.

[0056] Example 3

[0057] An oral stem cell factor complex, comprising 20% ​​by mass of a stem cell factor mixture, 12% albumin peptide, 12% yam peptide, 1.5% vitamin A, 1.2% vitamin C, 0.0012% niacin, 0.0012% vitamin B6, 0.0010% vitamin D, 0.08% pectin and the remainder of water, and then sterilizing and filling to obtain an oral stem cell factor complex. The preparation methods of the stem cell factor mixture, albumin peptide and yam peptide are the same as those in Example 1.

[0058] Comparative Example

[0059] The oral stem cell factor complex of Comparative Example 1 is different from that of Example 1 in that the composition contains albumin instead of albumin peptide; albumin was purchased from Shanghai Jiqi Biotechnology Co., Ltd., item number MP6110-5G.

[0060] The oral stem cell factor complex of Comparative Example 2 is different from that of Example 1 in that the composition contains yam instead of yam peptide.

[0061] Test example

[0062] Analysis of the effect of oral administration of stem cell factor complex on fasting blood glucose and insulin content in mice: 60 SPF-grade healthy male ICR mice were selected to construct a db / db diabetic mouse model. It was divided into an experimental group, a control group and a blank group, wherein experimental group 1 was a mouse oral administration of the stem cell factor complex shown in Example 1, experimental group 2 was a mouse oral administration of the stem cell factor complex shown in Example 2, experimental group 3 was a mouse oral administration of the stem cell factor complex shown in Example 3, control group 1 was a mouse oral administration of the stem cell factor complex shown in Comparative Example 1, control group 2 was a mouse oral administration of the stem cell factor complex shown in Comparative Example 2, and the blank group was an oral administration of an equal amount of normal saline. Oral administration was once in the morning and evening, 1 mL each time. All mice were fed with an equal amount of basic feed during the same period. After one week of feeding, each group of mice was fasted for 5 hours without water restriction, and the tail was cut to take blood to detect the fasting blood glucose level; then the eyeballs were removed to take blood, and the fasting serum insulin level was detected by radioimmunoassay.

[0063] The statistical results are shown in the following table: The oral stem cell factor complexes in Examples 1-3 of the present invention can reduce the blood sugar content in the diabetic mouse model and increase the insulin content (Table 1), further confirming that the oral stem cell factor complex of the present invention can effectively control blood sugar and promote the expression level of insulin secretion to achieve the treatment of diabetes. Compared with the comparative example, the separated and purified albumin peptide and yam peptide can effectively enhance and improve the efficacy of the oral stem cell factor complex, and have great application prospects.

[0064] Table 1. Analysis of the effects of oral administration of stem cell factor complex on fasting blood glucose and insulin levels in mice

[0065] Fasting blood glucose (mmol / L) Fasting insulin (μIU) Blank Group 45.88±1.56 17.25±4.22 Control group 1 38.45±2.52 18.95±2.54 Control group 2 30.22±1.45 22.67±3.57 Experimental Group 1 11.25±1.53 46.89±2.36 Experimental Group 2 8.27±3.51 48.56±2.58 Experimental Group 3 7.55±1.58 50.26±4.56

[0066] It is necessary to point out that the above embodiments are limited to further elaboration and explanation of the technical solution of the present invention, and are not further limitations of the technical solution of the present invention. The method of the present invention is only a preferred implementation scheme, and is not used to limit the protection scope of the present invention. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. An oral stem cell factor complex, characterized in that: The stem cell factor complex comprises 10-20% by mass of a stem cell factor mixture, 5-12% of albumin peptide, 5-12% of yam peptide, 0.5-1.5% of vitamin A, 0.2-1.2% of vitamin C, 0.001-0.0012% of niacin, 0.0002-0.0012% of vitamin B6, 0.0001-0.0010% of vitamin D, 0.01-0.08% of pectin and the remainder of water, and then sterilized and filled to obtain an oral stem cell factor complex.

2. The oral stem cell factor complex according to claim 1, characterized in that The oral stem cell factor complex comprises 10% by mass of a stem cell factor mixture, 5% albumin peptide, 5% yam peptide, 0.5% vitamin A, 0.2% vitamin C, 0.001% niacin, 0.0002% vitamin B6, 0.0001% vitamin D, 0.01% pectin and the remainder of water, and then sterilized and filled to obtain the oral stem cell factor complex.

3. The oral stem cell factor complex according to claim 1, characterized in that The oral stem cell factor complex comprises 15% by mass of a stem cell factor mixture, 8% albumin peptide, 8% yam peptide, 0.8% vitamin A, 0.6% vitamin C, 0.008% niacin, 0.0008% vitamin B6, 0.0008% vitamin D, 0.04% pectin and the remainder of water, and then sterilized and filled to obtain the oral stem cell factor complex.

4. The oral stem cell factor complex according to claim 1, characterized in that The oral stem cell factor complex comprises 20% by mass of a stem cell factor mixture, 12% of albumin peptide, 12% of yam peptide, 1.5% of vitamin A, 1.2% of vitamin C, 0.0012% of niacin, 0.0012% of vitamin B6, 0.0010% of vitamin D, 0.08% of pectin and the remainder of water, and then sterilized and filled to obtain the oral stem cell factor complex.

5. The oral stem cell factor complex according to any one of claims 1 to 4, characterized in that: The preparation method of the stem cell factor mixture comprises the following steps: 1) Obtain single cell suspension from bone marrow tissue digestion and sort CD29 using flow cytometry + CD31 + CD44 + CD14 - CD45 - of bone marrow mesenchymal stem cells; 2) Continuously subculture the bone marrow mesenchymal stem cells obtained in step 1) in DMEM basal culture medium; 3) collecting the supernatant of bone marrow mesenchymal stem cells from step 2) after three consecutive passages, filtering and sterilizing with a 0.22 μm filter membrane, and purifying and concentrating with an ultrafiltration membrane with a molecular weight cutoff of 20-50 KD to obtain a stem cell active factor concentrate; 4) freeze-drying the stem cell active factor concentrate in step 3) to prepare the stem cell factor mixture.

6. The oral stem cell factor complex according to any one of claims 1 to 4, characterized in that: The amino acid sequence of the albumin peptide is shown in SEQ ID NO.

1.

7. The oral stem cell factor complex according to claim 6, characterized in that The preparation method of the albumin peptide comprises: 1) washing the eggs, separating the yolk and the egg white, and freeze-drying the egg white to obtain freeze-dried egg white powder; 2) mixing the freeze-dried egg white powder with deionized water and adjusting the pH of the mixture to 2.0 to obtain an enzymatic base solution; 3) adding 10000U / g pepsin to the enzymatic hydrolysis base solution and performing enzymatic hydrolysis at a temperature of 37°C for 6 hours; after the enzymatic hydrolysis is completed, inactivating the enzyme at 90°C for 10 minutes; 4) Centrifuge at 5000 rpm for 10 min and take the supernatant; filter the supernatant using an ultrafiltration membrane with a molecular weight cutoff of 4000-5000 Da polypeptide molecules; 5) The albumin peptide is obtained by HPLC separation, purification and freeze-drying.

8. The oral stem cell factor complex according to any one of claims 1 to 4, characterized in that: The amino acid sequence of the yam peptide is shown in SEQ ID NO.

2.

9. The oral stem cell factor complex according to claim 8, characterized in that The preparation method of the yam peptide comprises: 1) Wash the yam, cut it into pieces, air-dry it at room temperature, and grind the air-dried yam pieces into powder for later use; 2) mixing the yam powder obtained in step 1) with water in a weight ratio of 1:5, and adjusting the pH value to 7.5; 3) adding papain in step 2) at a final concentration of 50%, and performing enzymatic treatment at a temperature of 37° C. for 6 h; 4) Centrifuge at 5000 rpm for 10 min and take the supernatant; filter the supernatant using an ultrafiltration membrane with a molecular weight cutoff of 4000-5000 Da polypeptide molecules; 5) The yam peptide is obtained by HPLC separation, purification and freeze-drying.

10. Use of the oral stem cell factor complex according to any one of claims 1 to 9 in preparing a blood sugar control preparation, characterized in that: The oral stem cell factor complex is used for treating diabetic patients.

Citation Information

Patent Citations

  • Antiaging nutrient composition and application

    CN107982280A

  • Oral stem cell factor compound and application thereof

    CN114042150A

  • Treatment of Insulin Resistance and Diabetes

    US20080260703A1